{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/36299"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/36299","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"HIV-1 entry in renal tubule epithelial cells through HSPG-dependent uptake pathways","abstract":"Human immunodeficiency virus (HIV) targets and depletes CD4+ T cells, compromising the body's ability to fight off infections. Progressed HIV disease can lead to impaired renal function known as HIV-associated nephropathy (HIVAN). Epithelial cells are typically ineffective targets of HIV-1 as they lack the CD4 and CCR5 molecules that are involved in viral entry into CD4+ T cells. However, previous research in the laboratory of Dr. Benjamin K. Chen demonstrated that renal tubule epithelial (RTE) cells were capable of viral uptake through a T cell-mediated, but CD4-independent mechanism. In addition, experiments implicated heparan sulfate proteoglycans (HSPG) as possible attachment receptors for HIV-1 through their heparan sulfate (HS) polysaccharide chains. The addition of anti-HSPG and anti-syndecan 1 antibodies blocked virus transfer by approximately 50%, suggesting a role for HSPG in viral entry. As a result, the syndecan (SDC) class of heparan sulfate receptors were assessed for their potential to serve as attachment receptors for HIV-1 through knockout studies. A co-culture system with donor HIV-expressing Jurkat T cells and target renal tubular epithelial (HK2) cells were used as a system for HIVAN pathogenesis and enabled cell-to-cell viral transfer. Despite the generation of stable SDC gene knockout lines, no change in viral transfer was observed, suggesting redundant or alternate pathways for HIV-1 entry. Understanding viral entry into epithelial cells is crucial as these sites can serve as reservoirs for HIV-1, where it can continue to replicate even when plasma viral load has been sufficiently reduced with antiretroviral treatment.","abstract_html":"Human immunodeficiency virus (HIV) targets and depletes CD4+ T cells, compromising the body&#x27;s ability to fight off infections. Progressed HIV disease can lead to impaired renal function known as HIV-associated nephropathy (HIVAN). Epithelial cells are typically ineffective targets of HIV-1 as they lack the CD4 and CCR5 molecules that are involved in viral entry into CD4+ T cells. However, previous research in the laboratory of Dr. Benjamin K. Chen demonstrated that renal tubule epithelial (RTE) cells were capable of viral uptake through a T cell-mediated, but CD4-independent mechanism. In addition, experiments implicated heparan sulfate proteoglycans (HSPG) as possible attachment receptors for HIV-1 through their heparan sulfate (HS) polysaccharide chains. The addition of anti-HSPG and anti-syndecan 1 antibodies blocked virus transfer by approximately 50%, suggesting a role for HSPG in viral entry. As a result, the syndecan (SDC) class of heparan sulfate receptors were assessed for their potential to serve as attachment receptors for HIV-1 through knockout studies. A co-culture system with donor HIV-expressing Jurkat T cells and target renal tubular epithelial (HK2) cells were used as a system for HIVAN pathogenesis and enabled cell-to-cell viral transfer. Despite the generation of stable SDC gene knockout lines, no change in viral transfer was observed, suggesting redundant or alternate pathways for HIV-1 entry. Understanding viral entry into epithelial cells is crucial as these sites can serve as reservoirs for HIV-1, where it can continue to replicate even when plasma viral load has been sufficiently reduced with antiretroviral treatment.","abstract_has_math":false,"creators":["Ali, Naushin S."],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Symes, Karen","Chen, Benjamin K."],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019","date_published":"2019","updated_at":"2026-11-18T20:24:23Z","subjects":["Immunology","HIV","HIVAN"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/36299","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/36299","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F36299","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Symes, Karen","Chen, Benjamin K."]},{"key":"dc:creator","label":"Author","values":["Ali, Naushin S."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-07-09T14:25:26Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-07-09T14:25:26Z"]},{"key":"dc:date.issued","label":"Date","values":["2019"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2019-06-11T01:02:38Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Immunology","HIV","HIVAN"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/36299"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Human immunodeficiency virus (HIV) targets and depletes CD4+ T cells, compromising the body's ability to fight off infections. Progressed HIV disease can lead to impaired renal function known as HIV-associated nephropathy (HIVAN). Epithelial cells are typically ineffective targets of HIV-1 as they lack the CD4 and CCR5 molecules that are involved in viral entry into CD4+ T cells. However, previous research in the laboratory of Dr. Benjamin K. Chen demonstrated that renal tubule epithelial (RTE) cells were capable of viral uptake through a T cell-mediated, but CD4-independent mechanism. In addition, experiments implicated heparan sulfate proteoglycans (HSPG) as possible attachment receptors for HIV-1 through their heparan sulfate (HS) polysaccharide chains. The addition of anti-HSPG and anti-syndecan 1 antibodies blocked virus transfer by approximately 50%, suggesting a role for HSPG in viral entry. As a result, the syndecan (SDC) class of heparan sulfate receptors were assessed for their potential to serve as attachment receptors for HIV-1 through knockout studies. A co-culture system with donor HIV-expressing Jurkat T cells and target renal tubular epithelial (HK2) cells were used as a system for HIVAN pathogenesis and enabled cell-to-cell viral transfer. Despite the generation of stable SDC gene knockout lines, no change in viral transfer was observed, suggesting redundant or alternate pathways for HIV-1 entry. Understanding viral entry into epithelial cells is crucial as these sites can serve as reservoirs for HIV-1, where it can continue to replicate even when plasma viral load has been sufficiently reduced with antiretroviral treatment."]},{"key":"dc:title","label":"Title","values":["HIV-1 entry in renal tubule epithelial cells through HSPG-dependent uptake pathways"]}]}],"canonical_facts":{"dc:contributor.advisor":["Symes, Karen","Chen, Benjamin K."],"dc:creator":["Ali, Naushin S."],"dc:date.accessioned":["2019-07-09T14:25:26Z"],"dc:date.available":["2019-07-09T14:25:26Z"],"dc:date.issued":["2019"],"dc:date.updated":["2019-06-11T01:02:38Z"],"dc:description.abstract":["Human immunodeficiency virus (HIV) targets and depletes CD4+ T cells, compromising the body's ability to fight off infections. Progressed HIV disease can lead to impaired renal function known as HIV-associated nephropathy (HIVAN). Epithelial cells are typically ineffective targets of HIV-1 as they lack the CD4 and CCR5 molecules that are involved in viral entry into CD4+ T cells. However, previous research in the laboratory of Dr. Benjamin K. Chen demonstrated that renal tubule epithelial (RTE) cells were capable of viral uptake through a T cell-mediated, but CD4-independent mechanism. In addition, experiments implicated heparan sulfate proteoglycans (HSPG) as possible attachment receptors for HIV-1 through their heparan sulfate (HS) polysaccharide chains. The addition of anti-HSPG and anti-syndecan 1 antibodies blocked virus transfer by approximately 50%, suggesting a role for HSPG in viral entry. As a result, the syndecan (SDC) class of heparan sulfate receptors were assessed for their potential to serve as attachment receptors for HIV-1 through knockout studies. A co-culture system with donor HIV-expressing Jurkat T cells and target renal tubular epithelial (HK2) cells were used as a system for HIVAN pathogenesis and enabled cell-to-cell viral transfer. Despite the generation of stable SDC gene knockout lines, no change in viral transfer was observed, suggesting redundant or alternate pathways for HIV-1 entry. Understanding viral entry into epithelial cells is crucial as these sites can serve as reservoirs for HIV-1, where it can continue to replicate even when plasma viral load has been sufficiently reduced with antiretroviral treatment."],"dc:identifier.uri":["https://hdl.handle.net/2144/36299"],"dc:language.iso":["en_US"],"dc:subject":["Immunology","HIV","HIVAN"],"dc:title":["HIV-1 entry in renal tubule epithelial cells through HSPG-dependent uptake pathways"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:24:23Z"}